MUMBAI, India, Feb. 6 -- Intellectual Property India has published a patent application (202511132241 A) filed by IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, on Dec. 26, 2025, for 'biologically constrained multi-omics repurposing platform and corresponding computational method.'
Inventor(s) include Nakul Gupta; Ravi Rawat; Shweta Sharma; and Sudhir Arora.
The application for the patent was published on Feb. 6, under issue no. 06/2026.
According to the abstract released by the Intellectual Property India: "A repurposing platform (100) is disclosed comprising a data harmonizer (102), a multi-omics graph assembler (104), a mechanistic constraint module (106), and a scoring and interpretation engine (108). The system (100) generates indication-specific biological graphs, embeds mechanistic restrictions including pathway direction, disease-aligned action, toxicity screening, and biomarker relevance, and produces a therapeutic suitability score for approved drugs. A method (200) includes constructing the graph structure (202), training a constraint-aware graph representation model (204), and producing prioritized drug-indication predictions with explanatory pathways and biomarker suggestions (206). Optional structural-biology triage enhances confidence in selected candidates. The invention improves interpretability, mechanistic grounding, and translational reliability of repurposing recommendations."
Disclaimer: Curated by HT Syndication.
